Valuation: Laboratorio Reig Jofre, S.A.

Market Cap 221M 255M 206M 189M 355M 24.27B 361M 2.42B 947M 12.17B 957M 936M 40.24B P/E 2026 *
13.6x
P/E 2027 * 22.6x
Enterprise Value 305M 353M 285M 262M 492M 33.59B 499M 3.35B 1.31B 16.84B 1.32B 1.3B 55.68B EV / Sales 2026 *
0.84x
EV / Sales 2027 * 0.76x
Free-Float
20.57%
Yield 2026 *
-
Yield 2027 * -
1 day-1.45%
1 week+1.88%
Current month+1.88%
1 month+1.12%
3 months-2.17%
6 months-1.09%
Current year+5.45%
1 week 2.66
Extreme 2.66
2.78
1 month 2.62
Extreme 2.62
2.78
Current year 2.32
Extreme 2.32
2.94
1 year 2.32
Extreme 2.32
3.35
3 years 2.15
Extreme 2.15
3.4
5 years 2.02
Extreme 2.02
5.28
10 years 1.87
Extreme 1.87
6.4
Manager TitleAgeSince
Chief Executive Officer 58 31/12/2005
Director of Finance/CFO - 19/12/2023
Chief Tech/Sci/R&D Officer - 31/12/2002
Director TitleAgeSince
Chairman - 30/12/2014
Director/Board Member 58 30/12/2014
Director/Board Member - 06/11/2017
Date Insider Type Main position Quantity % Market Cap.
01/12/22 Buy

Director

2,363 0.0030%
01/12/22 Buy

Director

1 0.0000%
01/12/22 Buy

Director

640 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-1.45%+1.88%-10.26%-2.87% 255M
-0.52%+3.21%+85.02%+161.12% 1,057B
+0.88%+1.13%+51.13%+49.76% 625B
+0.89%-1.95%+23.73%+63.67% 435B
+0.71%+3.87%+47.45%+38.68% 363B
+0.64%-0.49%+35.39%+40.21% 296B
+0.39%-5.83%+8.64%+9.28% 249B
+1.51%+6.69%+44.34%+62.47% 222B
+3.92%-0.46%-1.21%-44.09% 209B
+1.80%+2.30%+20.79%+65.13% 165B
Average +0.88%+0.97%+30.50%+44.34% 362.1B
Weighted average by Cap. +0.66%+1.22%+48.33%+75.33%

Financials

2026 *2027 *
Net sales 365M 422M 341M 313M 588M 40.15B 597M 4B 1.57B 20.13B 1.58B 1.55B 66.55B 392M 453M 366M 336M 631M 43.12B 641M 4.29B 1.68B 21.62B 1.7B 1.66B 71.47B
Net income 16.7M 19.3M 15.59M 14.31M 26.9M 1.84B 27.3M 183M 71.71M 921M 72.46M 70.88M 3.05B 9.5M 10.98M 8.87M 8.14M 15.3M 1.05B 15.53M 104M 40.79M 524M 41.22M 40.32M 1.73B
Net Debt 84.7M 97.88M 79.06M 72.56M 136M 9.32B 138M 928M 364M 4.67B 367M 360M 15.45B 78.7M 90.95M 73.46M 67.42M 127M 8.66B 129M 862M 338M 4.34B 341M 334M 14.35B
Logo Laboratorio Reig Jofre, S.A.
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Company’s activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
Employees
1,512
Date Price Change Volume
07/08/26 €2.710 -1.45% 6,904
06/08/26 €2.750 +0.36% 3,714
05/08/26 €2.740 +0.74% 4,146
04/08/26 €2.720 -1.09% 9,630
03/08/26 €2.750 +3.38% 16,028
Trader
-
Investor
Global
-
Quality
ESG MSCI
-

Annual profits - Rate of surprise